Acessibilidade / Reportar erro

Is religiosity/spirituality in patients with Crohn's disease important to their quality of life?

Abstract

The authors aim to study Religiosity/Spirituality (R/S) and Quality of Life (QoL) in patients with Crohn's disease and their correlation with the disease phenotypes.

Methods

Prospective cross-sectional cohort study with 151 consecutive patients enrolled from March 2021 to October 2021 at the Colorectal IBD Outpatient of Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo (HCFMUSP). Sociodemographic, Religiosity/Spirituality (Duke University Religion Index - Durel) questionnaires and QoL (Inflammatory Bowel Disease Questionnaire - Short IBDQ-S) were applied. When necessary, qualitative variables were evaluated using the chi-square or Fisher's exact test. The Mann-Whitney and Kruskall-Wallis tests were used to analyze quantitative variables and compare more than two groups, both non-parametric statistical techniques.

Results

The most frequent location was Ileocolonic followed by Ileal and colonic (41.1 %, 27.2 %, and 25.2 %); only 6.6 % of subjects had a perianal presentation. Inflammatory, stenosing, and penetrating behaviors showed 36.4 %, 19.1 %, and 44.4 % respectively. The majority of the population is Catholic, Evangelical, or Spiritualist (92.4 %). QoL score showed no significant difference in the phenotypes. The scores for DUREL domains were 61.4 % for organizational religiosity, 75 % for non-organizational religiosity, 98.6 %, 93.6 % and 89.3 % for intrinsic spirituality, with high results in all disease phenotypes.

Conclusions

The studied population presented homogeneous sociodemographic results and high religious and spiritual activity. R/S in a positive context were not associated with better QoL or phenotype. R/S is present in the patients’ lives and could be seen as an important tool for adherence to treatment and the professional relationship between doctor and patient. The homogeneity of the sample difficult for an appropriate evaluation, which leads us to suggest new studies with more heterogeneous groups.

Keywords
Quality of life; Spirituality; Crohn's disease; Chronic disease; Inflammatory bowel diseases; Coping

Highlight

  • Religiosity and spirituality in Inflammatory Bowel Disease should be further explored, being an important part of quality of life in the treatment goals of these patients.

  • Our article demonstrates that the need to evaluate the relationship between quality of life and religiosity and spirituality must be carried out in heterogeneous samples in order to be statistically significant.

  • The quality of life in the different phenotypes of Crohn's disease is not statistically significant

Highlight

  • Religiosity and spirituality in Inflammatory Bowel Disease should be further explored, being an important part of quality of life in the treatment goals of these patients.

  • Our article demonstrates that the need to evaluate the relationship between quality of life and religiosity and spirituality must be carried out in heterogeneous samples in order to be statistically significant.

  • The quality of life in the different phenotypes of Crohn's disease is not statistically significant

Introduction

Crohn's Disease (CD) is one of the most important presentations of Inflammatory Bowel Disease. Clinically characterized for being a chronic disease with periods of exacerbation represented by episodes of diarrhea several times a day with elimination of blood and mucus, abdominal cramps, weight loss, and logically very compromised quality of life.11 Loftus E.V. Jr. Crohn's Disease Etiology, Complications, Assessment, Therapy, and Management. Gastroenterol Clin North Am. 2017;46(3):xiii-xv.

2 M.P.B. Ferré, Boscá-Watts M.M., Pérez M.M. Crohn's disease. Med Clin (Barc). 2018;151(1):26-33.
-33 Roda G., Chien Ng S., Kotze P.G., Argollo M., Panaccione R., Spinelli A., et al. Crohn's disease. Nat Rev Dis Prim. 2020;6(1):22.

Its etiology has been increasingly elucidated, and it is estimated that genetically predisposed individuals and dysregulated immune response (innate and acquired) associated with microbiota antigens and environmental factors such as smoking and inadequate diet are the basis for triggers in the first and subsequent flare-ups. These triggers may have their origins in several areas: emotional, losses, infections, surgeries, etc.11 Loftus E.V. Jr. Crohn's Disease Etiology, Complications, Assessment, Therapy, and Management. Gastroenterol Clin North Am. 2017;46(3):xiii-xv.

2 M.P.B. Ferré, Boscá-Watts M.M., Pérez M.M. Crohn's disease. Med Clin (Barc). 2018;151(1):26-33.

3 Roda G., Chien Ng S., Kotze P.G., Argollo M., Panaccione R., Spinelli A., et al. Crohn's disease. Nat Rev Dis Prim. 2020;6(1):22.
-44 Petagna L., Antonelli A., Ganini C., Bellato V., Campanelli M., Divizia A., et al. Pathophysiology of Crohn's disease inflammation and recurrence Biol Direct. 2020;15(1):23.

Regarding histological and morphological presentation, the CD presents discontinuous lesions in the gastrointestinal mucosa, which can affect from the mouth to the anus, in a transmural process covering all layers of the organ, causing erosions, ulcerations, stenosis, formation of fistulas that communicate with other intestinal segments, other organs such as the bladder and vagina and the abdominal wall.44 Petagna L., Antonelli A., Ganini C., Bellato V., Campanelli M., Divizia A., et al. Pathophysiology of Crohn's disease inflammation and recurrence Biol Direct. 2020;15(1):23.

In addition to digestive manifestations, individuals with CD may have extra-intestinal manifestations and the most common are rheumatological, dermatological and ophthalmological.55 Rogler G., Singh A., Kavanaugh A., Rubin D.T. Extraintestinal Manifestations of Inflammatory Bowel Disease: current Concepts, Treatment, and Implications for Disease Management. Gastroenterology. 2021;161(4):1118-32.

The increase in incidence and prevalence is a fact, especially in newly industrialized areas in South America, Asia and Africa. This growth follows the higher rate of urbanization, occidental diet, smoking, sedentary lifestyle, and low rates of breastfeeding. The same scenario is found in Brazil and Europe.66 Kaplan G.G. The global burden of IBD: from 2015 to 2025. Nat Rev Gastroenterol Hepatol. 2015;12(12):720-7.

7 Datasus Ministry of Health, Brazil Ministério da Saúde. Secretaria Executiva Departamento de Informática do SUS, Rio de Janeiro: 2011. https://datasus.saude.gov.br.
https://datasus.saude.gov.br...
-88 Agrawal M., Christensen H.S., Bøgsted M., Colombel J.-.F., Jess T., Allin K.H., et al. The rising burden of inflammatory bowel disease in denmark over two decades: a nationwide cohort study. Gastroenterology. 2022;163(6):1547.

When the patient is diagnosed with a chronic, debilitating, and incurable disease faces the uncertainties and questions that must be answered by the assistant team. It is observed that the patient makes use of tools in the behavioral-cognitive area called coping, which varies according to their experience and understanding. Studies conclude that religiosity and spirituality find a place of action both in acceptance and adherence to treatment and clearly in quality of life.

The authors conceptualize religiosity as the practice of a religion, which is defined as a system of beliefs and practices carried out by a community, supported by rituals that recognize, venerate, and communicate with the Sacred and the Divine.

Spirituality is an individual's quest to understand existential issues (e.g., the end and meaning of life) and its relationship to the divine and/or transcendent and does not necessarily lead the patient to develop the practice of spirituality.99 Panzini R.G., Mosqueiro B.P., Zimpel R.R., Bandeira D.R., Rocha N.S., Fleck M.P., et al. Quality of life and spirituality. Int Rev Psychiatry. 2017;29(3):263-82.

10 Lucchetti G., Lucchetti A.L., Puchalski C.M. Spirituality in medical education: global reality? J Relig Health. 2012;51(1):3-19.

11 Freitas T.H., Hyphantis T.N., Andreoulakis E., Quevedo J., Miranda H.L., Alves G.S., et al. Religious coping and its influence on psychological distress, medication, adherence, and quality of life in inflammatory bowel disease. Braz J Psychiatry. 2015;37(3):219-27.

12 Naves Dias E.N., Ribeiro J.P. Folkman and Lazarus' coping model: historical and conceptual aspects. Rev Psicol Saude. 2019;11(2):55-66.
-1313 Campos R.J.D.S., Luchetti G., Luchetti A.L.G., Ribeiro T.C.R., Chebli L.A., Malaguti C., et al. The impact of spirituality and religiosity on mental health and quality of life of patients with active crohn's disease. J Relig Health. 2020;59(3):1273-86.

Because of the rising number of studies relating R/S feelings to chronic disease coping and having doctors and healthcare professionals aware of their role in supporting patients to achieve greater adherence to treatment.1414 Vander Weele T.J. Religion and health: A synthesis. Spirituality and Religion Within the Culture of medicine: From evidence to Practice. Oxford University Press. 2017.p 357-401.,1515 Notini L., Oakley J. When (if ever) may doctors discuss religion with their patients? bioeth. 2023;37(1):72-80. the authors' interests are to understand its importance to the different clinical presentations of Crohn´s disease.

The objective of this article is to study the quality of life of patients with Crohn's disease and understand the influence of Religiosity/Spirituality as an associated factor with the better quality of life of these patients and its relationship with the clinical presentation of the disease.

Methods

The study was carried out at the IBD outpatient clinic of the Coloproctology discipline of Hospital das Clínicas da FMUSP (HCFMUSP), from March to October 2021, with 151 consecutive patients.

The following inclusion criteria were: age 18 and 80 years with Crohn's disease diagnosed and classified in remission or mild to moderate activity by the Harvey-Bradshaw Index, with or without previous intestinal surgery, whose data were extracted from the medical records at the time of the study.

Exclusion criteria were: individuals with diagnostic doubts, unspecific and undetermined colitis, HIV carriers, patients with no cognitive capacity to fill out questionnaires, patients with severe comorbidities such as neurological, psychiatric, cardiovascular, pulmonary, renal failure, pregnant women, lactating women, patients with hypothyroidism, neoplasms and decompensated diabetes.

All patients signed the Free and Informed Consent Term (ICF).

Patients were classified with Harvey-Bradshaw Index and the Montreal Classification and S-IBDQ (Short ‒ Inflammatory Bowel Disease Questionnaire) and p-DUREL (Duke University Questionnaire - Religiosity) questionnaires were applied, both validated for the Portuguese language.

Qualitative variables were evaluated using the Chi-Square test or Fisher's exact test when necessary. The Mann-Whitney test was used to analyze quantitative variables and to compare more than 2 groups, the Kruskall-Wallis test was used, both non-parametric statistical techniques.1616 Satsangi J., Silverberg M.S., Vermeire S., Colombel J.-.F. The Montreal classification of inflammatory bowel disease: controversies, consensus, and implications. Gut. 2006;55(6):749-53.,1717 Harvey R.F., Bradshaw J.M. A simple index of Crohn's-disease activity. Lancet. 1980;1(8167):514-9.

Results

This study investigated 151 patients, 84 (56.6 %) were female and 67 (44.4 %). The age distribution is presented with a mean age of 45.2 years (±12.2-years). The socio-demographic evaluation questionnaire showed that the distribution of the individual's level of education is homogeneous from elementary to higher education. The most common income in the sample was 72.6 % up to 3 minimum wages, with married marital status being the most common, followed by single. Yet 92.4 % of the patients declared they belonged to a religion (Evangelical, Catholic, Spiritism and Jehovah's Witness).

The authors included in the questionnaire an assessment of emotional triggers and other areas (surgeries, diseases, other events) that could influence the onset of CD or its exacerbation and the result reported positively for these events was 81.7 % of respondents. Regarding leisure activities, a decrease of 20 % was detected (Tables 1-4).

Table 1
DC Location (segment) and Behaviour.
For better visualization of the following Tables, the authors transcribe the content of the questions of the DUREL Religiosity/Spirituality Index:
  1. How often do you go to a church, temple or other religious gathering? (Assessment of organizational religiosity).

  2. How often do you dedicate your time to individual religious activities, such as prayers, prayers, meditations, reading the bible or other religious texts? (Assessment of non-organizational religiosity).

  3. In my life, I feel the presence of God (or the Holy Spirit). (Assessment of intrinsic religiosity, spirituality).

  4. My religious beliefs are really behind my whole way of living. (Assessment of intrinsic religiosity, spirituality).

  5. I try very hard to live my religion in all aspects of life. (Assessment of intrinsic religiosity, spirituality).

The following Tables 1-4 bring us the distributions among the DC locations and behaviours (Table 1), answers to the quality of life IBDQ - short version (Table 2), the distribution answers in DUREL - religiosity and spirituality of Duke university scale (Table 3) and the Table 4 shows the distribution of the answers on DUREL table according to the DC location:

Table 2
Distribution of the answers and medium+Standard deviation to each category of the IBDQ (Short Version) Quality of life.
Table 3
Distribution of the answers on each question of DUREL.
Table 4
Distribution of the answers on DUREL according to DC location.

The Fig. 1 shows the distribution of the total score SIBDQ according to the location of the CD, which brings the non significant statistical results.

Fig. 1
Distribution of the total score SIBDQ according to the location of the CD (p-value based on the KW = 0.786).

There were also 8 other statistical confrontations that did not reach significance: the first three involving the R/E Index versus each of the CD behaviors (inflammatory, penetrating and fistulizing) and another 5 studies for each of the DUREL questions individually versus the SIBDQ quality of life index. The authors decided to deepen the statistical design in order to confirm the possibilities of significance, which was not observed.

Discussion

Through the analysis of the results of the socio-demographic questionnaire, the authors observed that the income level (72.6 % up to 3 minimum wages) and the high rate of belonging to a religion (92.4 %) leads us to classify the studied group as homogeneous in these areas. characteristics presented.

The fact that an individual declares himself to belong to a religion does not necessarily refer to the fact that he has a high level of religiosity and spirituality.

In 2017, Panzini brought a new concept of quality of life, which transcends the concept of absence of disease, and covers several domains: physical, psychological, and feeling of mental and spiritual well-being, which, according to individual perception, seeks a cultural context and the purpose of life.99 Panzini R.G., Mosqueiro B.P., Zimpel R.R., Bandeira D.R., Rocha N.S., Fleck M.P., et al. Quality of life and spirituality. Int Rev Psychiatry. 2017;29(3):263-82.

The quality of life assessed by the S-IBDQ questionnaire resulted in a median of 40 out of a total of 70; a minimum of 10 as a very bad QL and a maximum of 70 representing an excellent QoL. In comparison with the scientific literature, the authors observed a great diversity of statistics due to several factors involved, such as the profile of outpatients, service profile as a reference center, clinical phase of patients, psychological reception, adherence to treatment, etc.1818 Ficagna G.B., Dalri, J.L., Malutta E.F., Scolaro B.L., Bobato S.T. Quality of life of patients from a multidisciplinary clinic of inflammatory bowel disease. Arq Gastroenterol. 2020;57(1):8-12.

19 Knowles S.R., Kieffer L., Wilding H., Hewitt C., Keefer L., Mikocka-Walus A. Quality of life in inflammatory bowel disease: a systematic review and meta-analyses-part II. Inflamm Bowel Dis. 2018;24(5):966-76.
-2020 Thais K.V., Santos B.M., Santos C.H.M. Quality of life of patients with inflammatory bowel disease. J Coloproctol (Rio J). 2017;37(4):279-84.

The following statistical correlation studies were performed:
  1. Total quality of life score (IBDQ) versus disease location and behavior. There was no statistical significance, showing that regardless of CD location and behavior, patients' quality of life is affected in the same way.

    The initial question was to determine whether the difference in location and/or behavior exposed the patient to a difference in quality of life, a fact that was not materialized in this study.

  2. Religiosity/spirituality versus disease phenotypes and behavior (both for the total assessment and for each of the 5 questions of the DUREL index) and correlation between the total score of quality of life versus the answers for R/E (DUREL) and in all results were not observed significance.

The Inflammatory Bowel Disease Outpatient Clinic of the Discipline of Coloproctology at HC FMUSP, due to its complexity and for being an important reference in CD, presents homogeneity in sociodemographic characteristics, quality of life and R/S indexes regardless of phenotypes and behavior, a fact that makes it difficult to statistical analysis, as there are no parameters for comparison.

Since the study was carried out in a follow-up population for Crohn's disease, an important question raised was whether it had a high R/E index at the onset of symptoms or whether the evolution of the disease, with all its uncertainties, insecurities and suffering, led him to change its R/E index.1414 Vander Weele T.J. Religion and health: A synthesis. Spirituality and Religion Within the Culture of medicine: From evidence to Practice. Oxford University Press. 2017.p 357-401.,1515 Notini L., Oakley J. When (if ever) may doctors discuss religion with their patients? bioeth. 2023;37(1):72-80.

The results point to the continuity of investigations in the area. They invite further investigation from the cross-study of other factors and other samples. It would be important, for example, to work from a more heterogeneous sample with regard to the religious and sociodemographic profile of the patients. Investigating more deeply the spiritual and religious practices of the groups studied in relation to the treatment experience could also offer another type of understanding of the issue.

Conclusion

  1. The population treated at the Inflammatory Bowel Disease Outpatient Clinic of the Proctology Discipline of HC FMUSP is homogeneous in terms of religious characteristics (religious activity, organizational or not) and intrinsic spirituality present in a high degree.

  2. The degree of religiosity/spirituality is independent of CD phenotype and behavior.

  3. Positive Religiosity and spirituality do not present a correlation with better quality of life of patients in this study.

  4. The quality of life when studied and compared to the disease phenotypes did not present statistically significant results.

Disclosures

Nothing to disclose.

Writing assistance

None.

  • Grant support
    No support assistance for this study was necessary.

References

  • 1
    Loftus E.V. Jr. Crohn's Disease Etiology, Complications, Assessment, Therapy, and Management. Gastroenterol Clin North Am. 2017;46(3):xiii-xv.
  • 2
    M.P.B. Ferré, Boscá-Watts M.M., Pérez M.M. Crohn's disease. Med Clin (Barc). 2018;151(1):26-33.
  • 3
    Roda G., Chien Ng S., Kotze P.G., Argollo M., Panaccione R., Spinelli A., et al. Crohn's disease. Nat Rev Dis Prim. 2020;6(1):22.
  • 4
    Petagna L., Antonelli A., Ganini C., Bellato V., Campanelli M., Divizia A., et al. Pathophysiology of Crohn's disease inflammation and recurrence Biol Direct. 2020;15(1):23.
  • 5
    Rogler G., Singh A., Kavanaugh A., Rubin D.T. Extraintestinal Manifestations of Inflammatory Bowel Disease: current Concepts, Treatment, and Implications for Disease Management. Gastroenterology. 2021;161(4):1118-32.
  • 6
    Kaplan G.G. The global burden of IBD: from 2015 to 2025. Nat Rev Gastroenterol Hepatol. 2015;12(12):720-7.
  • 7
    Datasus Ministry of Health, Brazil Ministério da Saúde. Secretaria Executiva Departamento de Informática do SUS, Rio de Janeiro: 2011. https://datasus.saude.gov.br
    » https://datasus.saude.gov.br
  • 8
    Agrawal M., Christensen H.S., Bøgsted M., Colombel J.-.F., Jess T., Allin K.H., et al. The rising burden of inflammatory bowel disease in denmark over two decades: a nationwide cohort study. Gastroenterology. 2022;163(6):1547.
  • 9
    Panzini R.G., Mosqueiro B.P., Zimpel R.R., Bandeira D.R., Rocha N.S., Fleck M.P., et al. Quality of life and spirituality. Int Rev Psychiatry. 2017;29(3):263-82.
  • 10
    Lucchetti G., Lucchetti A.L., Puchalski C.M. Spirituality in medical education: global reality? J Relig Health. 2012;51(1):3-19.
  • 11
    Freitas T.H., Hyphantis T.N., Andreoulakis E., Quevedo J., Miranda H.L., Alves G.S., et al. Religious coping and its influence on psychological distress, medication, adherence, and quality of life in inflammatory bowel disease. Braz J Psychiatry. 2015;37(3):219-27.
  • 12
    Naves Dias E.N., Ribeiro J.P. Folkman and Lazarus' coping model: historical and conceptual aspects. Rev Psicol Saude. 2019;11(2):55-66.
  • 13
    Campos R.J.D.S., Luchetti G., Luchetti A.L.G., Ribeiro T.C.R., Chebli L.A., Malaguti C., et al. The impact of spirituality and religiosity on mental health and quality of life of patients with active crohn's disease. J Relig Health. 2020;59(3):1273-86.
  • 14
    Vander Weele T.J. Religion and health: A synthesis. Spirituality and Religion Within the Culture of medicine: From evidence to Practice. Oxford University Press. 2017.p 357-401.
  • 15
    Notini L., Oakley J. When (if ever) may doctors discuss religion with their patients? bioeth. 2023;37(1):72-80.
  • 16
    Satsangi J., Silverberg M.S., Vermeire S., Colombel J.-.F. The Montreal classification of inflammatory bowel disease: controversies, consensus, and implications. Gut. 2006;55(6):749-53.
  • 17
    Harvey R.F., Bradshaw J.M. A simple index of Crohn's-disease activity. Lancet. 1980;1(8167):514-9.
  • 18
    Ficagna G.B., Dalri, J.L., Malutta E.F., Scolaro B.L., Bobato S.T. Quality of life of patients from a multidisciplinary clinic of inflammatory bowel disease. Arq Gastroenterol. 2020;57(1):8-12.
  • 19
    Knowles S.R., Kieffer L., Wilding H., Hewitt C., Keefer L., Mikocka-Walus A. Quality of life in inflammatory bowel disease: a systematic review and meta-analyses-part II. Inflamm Bowel Dis. 2018;24(5):966-76.
  • 20
    Thais K.V., Santos B.M., Santos C.H.M. Quality of life of patients with inflammatory bowel disease. J Coloproctol (Rio J). 2017;37(4):279-84.

Publication Dates

  • Publication in this collection
    22 July 2024
  • Date of issue
    2024

History

  • Received
    11 July 2023
  • Reviewed
    04 Feb 2024
  • Accepted
    01 Apr 2024
Faculdade de Medicina / USP Rua Dr Ovídio Pires de Campos, 225 - 6 and., 05403-010 São Paulo SP - Brazil, Tel.: (55 11) 2661-6235 - São Paulo - SP - Brazil
E-mail: clinics@hc.fm.usp.br